Workflow
国际医学(000516) - 2014 Q1 - 季度财报
IMICIMIC(SZ:000516)2014-04-24 16:00

Financial Performance - The company's operating revenue for Q1 2014 was ¥1,055,541,039.65, representing a 3.73% increase compared to ¥1,017,584,073.62 in the same period last year[7] - Net profit attributable to shareholders increased by 44.57% to ¥66,130,329.86 from ¥45,743,475.72 year-on-year[7] - The net profit after deducting non-recurring gains and losses was ¥63,376,459.58, up 35.51% from ¥46,767,172.03 in the previous year[7] - Basic and diluted earnings per share increased by 50.00% to ¥0.09 from ¥0.06 year-on-year[7] Cash Flow and Assets - The net cash flow from operating activities decreased by 142.78%, resulting in a negative cash flow of ¥25,959,528.65 compared to a positive cash flow of ¥60,683,652.76 in the same period last year[7] - Total assets decreased by 14.82% to ¥3,076,353,381.41 from ¥3,611,639,071.57 at the end of the previous year[7] - Net assets attributable to shareholders increased by 5.17% to ¥1,345,564,785.40 from ¥1,279,434,455.54 at the end of the previous year[7] - Cash and cash equivalents net increase decreased by 1,123.76% year-on-year, mainly due to the repayment of short-term financing bonds[13] Investments - Investment income increased by 269.08% compared to the same period last year, primarily due to increased securities investment income[13] - The company holds 1,288,400 shares of Hengji Daxin, representing 100% of the initial investment cost of 17,998.75 CNY, with a current value of 23,577.72 CNY, resulting in a profit of 2,705,640 CNY[17] - The company has a long-term equity investment in Hai Tian Tian Xian Technology Co., Ltd. with an initial investment of 14.6 million CNY, maintaining a 15.45% ownership stake[17] - The company has not reported any derivative investments as of the reporting period[18] Commitments and Guarantees - The company has committed to not selling its non-tradable shares for 60 months at a price lower than 12.00 CNY per share after the lock-up period[15] - The net profit for the three accounting years from 2012 to 2014 is guaranteed to be no less than 20.84 million CNY, 31.67 million CNY, and 42.18 million CNY respectively[15] Corporate Activities - The company reported no significant events during the reporting period[14] - The company has conducted multiple institutional research activities to discuss its operational development, including meetings with Tai Kang Asset and Guotai Junan Securities[20]